2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Germinoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, MP; Guan, J; Hasni, MS; Okret, S; Sander, B; Yakimchuk, K | 1 |
| Pfreundschuh, M; Roemer, K; Römer, K | 1 |
2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Germinoblastoma
| Article | Year |
|---|---|
Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Estrogen Receptor beta; Humans; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasm Metastasis; Neovascularization, Pathologic; Nitriles; Propionates; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2014 |
How do estrogens control lymphoma?
Topics: Angiogenesis Inhibitors; Animals; Estrogen Receptor beta; Humans; Lymphoma; Male; Neovascularization, Pathologic; Nitriles; Propionates | 2014 |